Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Lymphocytes and their Roles in Cancer (R1)

joint with the meeting on Emerging Cellular Therapies: T Cells and Beyond (B6)

Scientific Organizers: Iannis Aifantis, Ugur Sahin and Mikala Egeblad


February 11—15, 2018

Keystone Resort, Keystone, Colorado, USA


Sponsored by Amgen Inc., BioLegend, Inc. and Incyte Corporation


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Oct 11, 2017 [details]
Discounted Abstract Deadline: Oct 11, 2017 [details]
Abstract Deadline: Dec 13, 2017 [details]
Discounted Registration Deadline: Dec 13, 2017 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-R1 "Lymphocytes and their Roles in Cancer" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 11, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 11, 2017 until December 31, 2017 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 11, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 13, 2017 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 13, 2017 1020.00 USD
Discounted STUDENT Registration
More details
Before and On December 13, 2017 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 13, 2017 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 11, 2017


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 13, 2017)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 11, 2017


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 13, 2017


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 11, 2017)

Discounted Registration Deadline: December 13, 2017


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 11 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 15 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, February 16 in order to fully experience the meeting.

SUNDAY, FEBRUARY 11

16:00—20:00
Arrival and Registration

Longs Peak Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, FEBRUARY 12

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Alexander Y. Rudensky, HHMI/Memorial Sloan Kettering Cancer Center, USA
Regulatory T Cells and their Functions in the Tumor Microenvironment

08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Ton N. Schumacher, Netherlands Cancer Institute, Netherlands
T Cell Recognition in Human Cancer

09:00—11:15
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Louis M. Staudt, National Cancer Institute, NIH, USA
The MYD88-TLR9-B Cell Receptor Complex as a Target for Therapy in Aggressive Lymphomas

Coffee Break

Charles G. Mullighan, St. Jude Children's Research Hospital, USA
Biology of Relapse in Acute Lymphoblastic Leukemia

Katia Georgopoulos, Massachusetts General Hospital, USA
Early Events in Lymphocytic Differentiation and Transformation

Short Talk(s) Chosen from Abstracts

09:00—11:15
CAR/TCR Preclinical
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Philip D. Greenberg, University of Washington, USA
Making TCR-Modified T Cells Effective for Leukemia and Solid Tumors

Coffee Break

Crystal L. Mackall, Stanford University, USA
CAR T Cells in Pediatric Malignancies

Stanley R. Riddell, Fred Hutchinson Cancer Research Center, University of Washington, USA
Strategies to Improve the Efficacy of CAR T Cells in Solid Tumors

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
14:30—16:30
Workshop 1

Short Talks Chosen from Abstracts

14:30—16:30
Workshop 1: Perspectives from Industry and FDA: Roundtable

Grays/Longs Peak
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Therapeutic Targeting of Lymphocytic Malignancy
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Irene M. Ghobrial, Dana-Farber Cancer Institute, USA
Targeting the Tumor Microenvironment in Multiple Myeloma

Adolfo Ferrando, Columbia University, USA
Epigenetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia

Iannis Aifantis, New York University School of Medicine, USA
Targeting the Tumor Microenvironment in Acute Lymphoblastic Leukemia

Short Talk Chosen from Abstracts

17:00—19:00
Synthetic Biology
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Darrell J. Irvine, Massachusetts Institute of Technology, USA
Chemically engineering T cell therapies

Wendell A. Lim, University of California, San Francisco, USA
Optimizing Synthetic Biology Tools for T Cell Therapies

Travis Young, California Institute for Biomedical Research, USA
Controllable CAR-T Cell Therapy

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 1

Colorado Rockies Ballroom

TUESDAY, FEBRUARY 13

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Cellular Therapies in Blood Malignancies and Beyond
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Carl H. June, University of Pennsylvania, USA
CAR T Cells and their Therapeutic Promise in the Treatment of Leukemia

Crystal L. Mackall, Stanford University, USA
Recent Updates of Chimeric Antigen Receptor Clinical Trials

Coffee Break

Chiara Bonini, Vita- Salute San Raffaele University, Italy
Gene Editing of Memory Stem T Cells for Cancer Immunotherapy

Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA
Next Generation CAR-T Cell-Expressing Vectors and in vivo Utilization

Short Talk(s) Chosen from Abstracts

08:00—11:00
Engineered T Cells for HIV
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Catherine M. Bollard, Children’s National Health System, USA
Developing HIV-specific T Cell Therapies: Lessons from EBV

Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Shutting the Door on HIV by Engineering Hematopoietic Stem Cells

Coffee Break

James L. Riley, University of Pennsylvania, USA
Engineering T Cells to Functionally Cure HIV-1 Infection

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Lymphocytes as Elements of the Tumor Microenvironment
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
David H. Raulet, University of California, Berkeley, USA
Immune Surveillance of Cancer Cells by Natural Killer Cells

Michael Kalos, Eli Lilly and Company, USA
T Cells in the Microenvironment: Conductors, First Violin, or Part of the Orchestra?

Lisa M. Coussens, Oregon Health & Science University, USA
Dynamic Interactions Between Myeloid and Lymphoid cells Regulate Response to Therapy in Solid Tumors

Short Talk Chosen from Abstracts

17:00—19:00
CAR/TCR in the Clinic for Cancer
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Stephen J. Forman, City of Hope, USA
CAR Trials in the Clinic

Marcela V. Maus, Harvard Medical School, USA
CAR T Cells Multiple Myeloma and Glioblastoma

Saar I. Gill, University of Pennsylvania, USA
CAR T Cells for Acute Myelogenous Leukemia

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 2

Colorado Rockies Ballroom

WEDNESDAY, FEBRUARY 14

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:15
Emerging Technologies: Visualization and Dissection of the Tumor Microenvironment
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Dana Pe'er, Memorial Sloan Kettering Cancer Center, USA
A Single Cell Approach to Understanding the Tumor Microenvironment

Matthew F. Krummel, University of California, San Francisco, USA
Imaging a World Beyond Checkpoints: Innate Partners for Lymphocytes in Cancer

Coffee Break

Jerome Galon, INSERM U872, Cordeliers Research Center, France
Immunoscore as a Stronger Predictor of Patient Survival in Colorectal Cancer

Michael Goldberg, Dana-Farber Cancer Institute, USA
Enhancing cancer immunotherapy through immuno-engineering

Short Talk(s) Chosen from Abstracts

08:00—11:00
Tregs as Cellular Therapeutics
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Bruce R. Blazar, University of Minnesota, USA
Vimentin Restrains Regulatory T-cell Suppression of Graft-versus-Host Disease

Jeffrey A. Bluestone, University of California, San Francisco, USA
Manipulating Tregs to Control Tolerance in Autoimmunity and Cancer

Coffee Break

Megan K. Levings, University of British Columbia, Canada
HLA-A2 Directed CAR Tregs

Laurence A. Turka, Massachusetts General Hospital, USA
Alloantigen-specifc Tregs for Solid Organ Transplantation

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

14:30—16:30
Workshop 2: Late Breaking Talks

Grays/Longs Peak
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Emerging Concepts in the Development of Tumor Vaccines
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Ugur Sahin, TRON – Translationale Oncology, Germany
Systemic RNA Delivery, Dendritic Cell Vaccines and Implications for Cancer Immunotherapy

Cornelis J. M. Melief, Leiden University Medical Center, Netherlands
Combination Immunotherapy of Cancers caused by High Risk HPV16

Johanna Olweus, University of Oslo, Norway
Selecting Immunogenic Targets for Cancer Immunotherapy

Short Talk Chosen from Abstracts

17:00—19:00
Beyond T Cells: HSC, T Progenitor, and IPSCs I
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Speaker to be Announced

Martin Pule, University College London, UK
New Designs in Synthetic T Cells

Jeffrey Steven Miller, University of Minnesota, USA
Novel Ways to Activate and Target NK Cells to Treat Cancer

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom

THURSDAY, FEBRUARY 15

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Combinatorial Treatments and their Effects on Lymphocyte Function in Cancer
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
David G. DeNardo, Washington University Medical School, USA
The Pancreatic Tumor Microenvironment; Modulator of Tumor Progression and Response to Therapy

Dimitris Skokos, Regeneron Pharmaceuticals, USA
T Cell Dysfunction and Combination Immunotherapy

Coffee Break

Michael A. Curran, University of Texas MD Anderson Cancer Center, USA
Optimizing T Cell Frequency and Function via Checkpoint Antibody / Vaccine Combinations

Sjoerd H. van der Burg, LUMC, Netherlands
Combination Treatments to Modulate the Microenvironment and Boost Tumor-specific T cells

Short Talk(s) Chosen from Abstracts

08:00—11:00
Beyond T Cells: HSC, T Progenitor, and IPSCs II
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Juan Carlos Zúñiga-Pflücker, Sunnybrook Research Institute, Canada
Generation of Human Progenitor T Cells from Stem Cells

Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA
iPS-Derived Genetically-Modified T Cells

Coffee Break

Jakub Tolar, University of Minnesota, USA
Gene Edited Stem Cells: From Cloning to Clinic

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 2

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—18:45
Future Directions for Next Generation Sequencing: Genomics, Epigenetics and Immunogenomics
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
Mikala Egeblad, Cold Spring Harbor Laboratory, USA
Visualization of the Switch from Immune Control to Immune Escape

Mickey Atwal, Cold Spring Harbor Laboratory, USA
High Throughput Profiling of T Cell Receptor Sequences in Cancer Immunotherapy

Manel Esteller, Belvitge Biomedical Research Institute (IDIBELL), Spain
Cancer Epigenetics: From Knowlegde to Applications

17:00—18:45
Intersection of Genetic Editing and Cellular Therapy
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
Alex Marson, University of California, San Francisco, USA
Talk Title to be Announced

Andrew M. Scharenberg, Casebia Therapeutics, USA
Editing T-Cells for Adoptive Therapy of Inflammatory Disorders

Carl H. June, University of Pennsylvania, USA
Adoptive Transfer with Genetically Edited T Cells

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/11/2018

Quandary Peak
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/11/2018

Grays/Longs Peak
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Colorado Rockies Ballroom

FRIDAY, FEBRUARY 16

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Amgen Inc. BioLegend, Inc.
Incyte Corporation
 

We gratefully acknowledge additional support for this conference from:

American Association for Cancer Research (AACR) Bethyl Laboratories, Inc.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676